- Home
- VERU vs DMA Comparison
VERU vs DMA Comparison
Compare VERU & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERU
- DMA
- Stock Information
- Founded
- VERU 1971
- DMA 2011
- Country
- VERU United States
- DMA United States
- Employees
- VERU N/A
- DMA N/A
- Industry
- VERU Biotechnology: Pharmaceutical Preparations
- DMA Trusts Except Educational Religious and Charitable
- Sector
- VERU Health Care
- DMA Finance
- Exchange
- VERU Nasdaq
- DMA Nasdaq
- Market Cap
- VERU 85.5M
- DMA 78.0M
- IPO Year
- VERU 1990
- DMA N/A
- Fundamental
- Price
- VERU $3.45
- DMA $8.78
- Analyst Decision
- VERU Strong Buy
- DMA
- Analyst Count
- VERU 3
- DMA 0
- Target Price
- VERU $33.33
- DMA N/A
- AVG Volume (30 Days)
- VERU 139.0K
- DMA 34.6K
- Earning Date
- VERU 08-12-2025
- DMA 01-01-0001
- Dividend Yield
- VERU N/A
- DMA 2.04%
- EPS Growth
- VERU N/A
- DMA N/A
- EPS
- VERU N/A
- DMA N/A
- Revenue
- VERU $16,886,419.00
- DMA N/A
- Revenue This Year
- VERU N/A
- DMA N/A
- Revenue Next Year
- VERU N/A
- DMA N/A
- P/E Ratio
- VERU N/A
- DMA N/A
- Revenue Growth
- VERU 337.24
- DMA N/A
- 52 Week Low
- VERU $2.64
- DMA $4.78
- 52 Week High
- VERU $14.20
- DMA $8.00
- Technical
- Relative Strength Index (RSI)
- VERU 42.63
- DMA 63.06
- Support Level
- VERU $3.24
- DMA $8.55
- Resistance Level
- VERU $3.94
- DMA $8.83
- Average True Range (ATR)
- VERU 0.22
- DMA 0.07
- MACD
- VERU 0.10
- DMA 0.01
- Stochastic Oscillator
- VERU 31.94
- DMA 84.20
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.